Juana Merino

Av. Pío XII 36
Pamplona, NC 31008, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Clinical implications of changing thyroglobulin and antithyroglobulin antibodies analytical methods in the follow-up of patients with differentiated thyroid carcinoma.

Clinical implications of changing thyroglobulin and antithyroglobulin antibodies analytical methods in the follow-up of patients with differentiated thyroid carcinoma.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: May 31, 2023

FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunology.

FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunology.

Journal: Blood advances

Published: May 07, 2021

Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma.

Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma.

Journal: Blood

Published: December 20, 2019

Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma.

Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma.

Journal: Blood

Published: September 20, 2019

Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC).

Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC).

Journal: Blood cancer journal

Published: September 10, 2018

Flow Cytometry.

Flow Cytometry.

Journal: Hematology/oncology clinics of North America

Published: September 08, 2018

The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma.

The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 22, 2018

Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis.

Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis.

Journal: Leukemia

Published: May 07, 2018

Utility of flow cytometry studies in the management of patients with multiple myeloma.

Utility of flow cytometry studies in the management of patients with multiple myeloma.

Journal: Current opinion in oncology

Published: September 09, 2016

Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma Treatment.

Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma Treatment.

Journal: Cancer cell

Published: June 09, 2016

First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study.

First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study.

Journal: European journal of haematology

Published: May 24, 2016

Diagnostic screening of paroxysmal nocturnal hemoglobinuria: Prospective multicentric evaluation of the current medical indications.

Diagnostic screening of paroxysmal nocturnal hemoglobinuria: Prospective multicentric evaluation of the current medical indications.

Journal: Cytometry. Part B, Clinical cytometry

Published: March 30, 2016

Showing 1-12 of 21

Last Updated: 09/26/2026